Hristo Aladjov, Brussels, 2 Sep. 2018

Slides:



Advertisements
Similar presentations
Framework for the Ecological Assessment of Impacted Sediments at Mining Sites in Region 7 By Jason Gunter (R7 Life Scientist) and.
Advertisements

Perspectives from EPA’s Endocrine Disruptor Screening Program
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Mechanisms of Thyroid Toxicity Kevin M. Crofton Neurotoxicology Division National Health and Environmental Effects Laboratory US Environmental Protection.
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Supervised and Unsupervised learning and application to Neuroscience Cours CA6b-4.
Parameterising Bayesian Networks: A Case Study in Ecological Risk Assessment Carmel A. Pollino Water Studies Centre Monash University Owen Woodberry, Ann.
General Unified Threshold model for Survival (GUTS)
VESTEL database realistic telephone speech corpus:  PRNOK5TR: 5810 utterances in the training set  PERFDV: 2502 utterances in testing set 1 (vocabulary.
What Do Toxicologists Do?
1 Issues in Harmonizing Methods for Risk Assessment Kenny S. Crump Louisiana Tech University
Environmental Risk Analysis
Committee on Carcinogenicity (COC) Approach to Risk Assessment of Genotoxic Carcinogens David H. Phillips* COC Chairman Descriptive vs. Quantitative.
Tjalling Jager Dept. Theoretical Biology Assessing ecotoxicological effects on a mechanistic basis the central role of the individual.
In Silico Simulation of a Translational Human Breast Cancer Model in Mice March 25 th, 2013 Mark Dawidek Department of Medical Biophysics.
NEURAL NETWORKS FOR DATA MINING
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 01 - INTRODUCTION.
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 10 – BIOMARKERS Introduction.
Supplementary Fig. 2. Statistical Classification Analysis Results. Box and whisker plots displaying mean performance metrics returned in the assessment.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
Which information identifies a chemical as endocrine disrupting? Poul Bjerregaard Institute of Biology University of Southern Denmark Odense and Danish.
Criterion 1: Conservation of Biological Diversity Indicator Refinement: What is the state of Indicator Science? 1. Overview of the Criterion 2. Review.
MECHANISTIC MODEL OF STEROIDOGENESIS IN FISH OVARIES TO PREDICT BIOCHEMICAL RESPONSE TO ENDOCRINE ACTIVE CHEMICALS Michael S. Breen, 1 Miyuki Breen, 2.
EE3561_Unit 4(c)AL-DHAIFALLAH14351 EE 3561 : Computational Methods Unit 4 : Least Squares Curve Fitting Dr. Mujahed Al-Dhaifallah (Term 342) Reading Assignment.
Centre for the Study of Learning and Performance: Systematic Review Theme Robert M. Bernard (Theme Leader) Philip C. Abrami Richard F. Schmid Anne Wade.
Air Toxics Risk Assessment: Traditional versus New Approaches Mark Saperstein BP Product Stewardship Group.
Supplementary Fig. 1. Statistical Classification Analysis Results. Box and whisker plots displaying mean performance metrics returned in the assessment.
OECD’s work on Adverse outcome pathways
How Good is a Model? How much information does AIC give us? –Model 1: 3124 –Model 2: 2932 –Model 3: 2968 –Model 4: 3204 –Model 5: 5436.
Adaptive Integrated Framework (AIF): a new methodology for managing impacts of multiple stressors in coastal ecosystems A bit more on AIF, project components.
McKim Workshop on Strategic Approaches for Reducing Data Redundancy in Cancer Assessment Duluth, MN, USA 19 May, 2010.
© 2015, Selventa. All Rights Reserved. Confidential Overview of Adverse Outcome Pathway (AOP) 1.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
Considerations for Developing Alternative Health Risk Assessment Approaches for Addressing Multiple Chemicals, Exposures and Effects External Review Draft.
NICNAS Reforms Community Stakeholder Workshop. Input from non-industry stakeholders on NICNAS Reforms Working within parameters of Government decision.
provided by the Ministry of the Interior of the Czech republic.
FIFRA SAP Meeting February 2, 2010
Evaluating Cumulative Impacts: The Value of Epidemiology
10 – BIOMARKERS Introduction
Visualization of Adverse effect pathways
Molecular Therapy - Nucleic Acids
Decision Contexts in a Changing Toxicology Paradigm
Adverse Outcome Pathway Networks and the AOP Knowledgebase
Which information identifies a chemical as endocrine disrupting?
AOPs, biological networks, and data analysis
Introduction to the AOP-Wiki
Evaluating AOP Evidence
Recurrent Neural Networks
Finding the Area Between Curves
Food Chemicals Toxicity
Multidimensional Drug Profiling By Automated Microscopy
Integrative approach for drug discovering
Today (2/23/16) Learning objectives:
Molecular Therapy - Nucleic Acids
Function Notation “f of x” Input = x Output = f(x) = y.
Volume 96, Issue 5, Pages (March 2009)
Volume 10, Issue 2, Pages (February 2012)
IDEA International Dialogue for the Evaluation of Allergens
DICOM – A Preclinical Perspective
Evaluating Cumulative Impacts: The Value of Epidemiology
Section 5.3: Finding the Total Area
Predicting Changes in Graphs
Research needs derived from MODELKEY findings
Cec6- TRAINING ON BUILDING QUANTITATIVE AOP
EFSA’s Chemical Hazards Database
Jos van Gils, Elena Semenzin, Muriel Gevrey, Peter Von der Ohe,
Guidance on establishing nutrient concentrations to support good ecological status Introduction and overview Martyn Kelly.
Introduction to Risk Assessment
Goodfellow: Chapter 14 Autoencoders
Presentation transcript:

Hristo Aladjov, Brussels, 2 Sep. 2018 & Quantitative AOPs Hristo Aladjov, Brussels, 2 Sep. 2018

Effectopedia – Intersection of frameworks ADME AOP Effectopedia – Intersection of frameworks q MIE Aromatase Inhibition KE1 Reduced E2 synthesis AO Population Reduction … Stressor Fadrozole internal Fadrozole external Experimental In-Vitro f(x) In-Vivo In-Vitro f(x) In-Silico Model f(x) Modelling

ADME AOP ADME & qAOP q MIE Aromatase Inhibition KE1 Reduced E2 synthesis AO Population Reduction … Stressor Fadrozole internal Fadrozole external time dose Stressor (external) time dose Stressor (at target) time response MIE time response KE1 time response AO The input of the qAOP model is the dose-time data for the stressor measured at the target site Use toxicokinetics to extend the predictive power of qAOP (so they can be used as alternative to in-vivo animal models)

Experimental evidences - qAOPs time dose Stressor (at target) time response KE1 MIE Aromatase Inhibition KE1 Reduced E2 synthesis AO Population Reduction … time dose Stressor (at target) time response MIE MIE Aromatase Inhibition KE1 Reduced E2 synthesis In-Vitro f(x) In-Vivo In-Vitro f(x) time Assay response In-Vitro1 time dose Stressor (Media 1) f(x) In-Vitro 1 time Assay response In-Vitro 2 time dose Stressor (Media 2) f(x) In-Vitro 2

Experimental evidences - qAOPs KE need to be measurable we know how to interpret a measurement we know how define the test response mapping. Test response mapping transforms the output of the assay into in-vivo relevant data, comparable across KE In case of chemical stressors ADME is important basis for comparing the assay and in-vivo model thus helps define the test response mapping. MIE Aromatase Inhibition KE1 Reduced E2 synthesis AO Population Reduction … MIE Aromatase Inhibition KE1 Reduced E2 synthesis In-Vitro f(x) In-Vivo In-Vitro f(x) f(x) In-Vitro 1 f(x) In-Vitro 2

Experimental design and modelling Creating an qAOP is iterative process Quantify the AOP using the existing data Create initial models Identify data gaps and uncertainties Measure and publish the data which will be useful for parametrization of the models. MIE Aromatase Inhibition KE1 Reduced E2 synthesis AO Population Reduction … In-Vitro f(x) In-Vivo In-Vitro f(x) In-Silico Model f(x)

qAOP networks – the functional unit of predictions Chemical 1 MIE1 KE KE KE AO1 Chemical 2 MIE2 KE KE AO2 Chemical 3 MIE3 KEX KE AO3 Chemical 4 MIE4 KEY KE AO4 Chemical 5 MIE5 KE KE KE AO5 Analysis of the most sensitive AO Single MIE can trigger multiple AOs Alternative test prioritisation Toxicity of mixtures Chemical2 Chemical4 Chemical5 concentration

In-silico models in Effectopedia Several types of models - dose response, response response, ADME, … Models use input, output and model parameter conventions to integrate with Effectopedia No restrictions on the methods used – curve fitting, statistical, system biology models, deep learning … Currently supported R, MATLAB, Java, more to come Single model can cover more than one KE Feedbacks / feedforward should be handled internally in the model covering all involved KE MIE Aromatase Inhibition KE1 Reduced E2 synthesis KE2 Reduced E2 plasma concentrations HPG axis model